SCHEMBL5201238

SCHEMBL5201238

CC(c1ccc(Cl)cc1)C(CNC(=O)C1(c2ccccc2)CCCO1)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 9/20 0.45
ITGA4 P13612 9/20 0.45
ITGB7 P26010 9/20 0.45
EPHX1 P07099 1/20 0.38
EPHX2 P34913 1/20 0.38
SLC6A2 P23975 1/20 0.37
SLC6A4 P31645 1/20 0.37
SLC6A3 Q01959 1/20 0.37
ALDH1A1 P00352 2/20 0.36
P2RX7 Q99572 1/20 0.36
GPR139 Q6DWJ6 1/20 0.36
GRIN2B Q13224 1/20 0.36
CNR1 P21554 1/20 0.35
MEN1 O00255 1/20 0.34
RAB9A P51151 1/20 0.34
KMT2A Q03164 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
SLC6A9 P48067 1/20 0.34
SLC6A5 Q9Y345 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5200569 0.82 TRPA1 (0.46) SLC6A2SLC6A4SLC6A3ALDH1A1GPR139
SCHEMBL5202582 0.81 MEN1 (0.38) ITGB1ITGA4ITGB7ALDH1A1P2RX7
SCHEMBL4825610 0.80 ITGB1 (0.56) ITGB1ITGA4ITGB7CNR1
SCHEMBL5203380 0.77 HDAC4 (0.42) SLC6A2SLC6A4SLC6A3CNR1SMN1; SMN2
SCHEMBL5200440 0.76 ALDH1A1 (0.48) ITGA4ITGB7ALDH1A1P2RX7CNR1
SCHEMBL5202615 0.75 ALDH1A1 (0.43) ITGA4ITGB7ALDH1A1P2RX7CNR1
SCHEMBL5205537 0.74 HDAC4 (0.42) SLC6A2SLC6A4ALDH1A1P2RX7MEN1
SCHEMBL5202986 0.73 KMT2A (0.40) SLC6A2SLC6A4P2RX7CNR1MEN1
SCHEMBL5262774 0.72 SLC6A9 (0.54) SLC6A2SLC6A4SLC6A3P2RX7GPR139
SCHEMBL5480925 0.70 PPARA (0.36) SLC6A2SLC6A4SLC6A3ALDH1A1P2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1490043-A4 SPIROCYCLIC AMIDES AS CANNABINOID RECEPTOR MODULATORS MERCK & CO INC (US) 2007-05-30 EP claimed
EP-1490043-A2 SPIROCYCLIC AMIDES AS CANNABINOID RECEPTOR MODULATORS Merck & Co., Inc. (US) 2004-12-29 EP claimed
WO-2003082190-A2 SPIROCYCLIC AMIDES AS CANNABINOID RECEPTOR MODULATORS MERCK & CO., INC. (US) 2003-10-09 WO claimed
EP-1490043-A4 SPIROCYCLIC AMIDES AS CANNABINOID RECEPTOR MODULATORS MERCK & CO INC (US) 2007-05-30 EP disclosed
EP-1490043-A2 SPIROCYCLIC AMIDES AS CANNABINOID RECEPTOR MODULATORS Merck & Co., Inc. (US) 2004-12-29 EP disclosed
WO-2003082190-A2 SPIROCYCLIC AMIDES AS CANNABINOID RECEPTOR MODULATORS MERCK & CO., INC. (US) 2003-10-09 WO disclosed